background image

Paid Clinical Trials Norfolk

Discover 392 paid clinical trials in Norfolk, Virginia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
FeaturedActive & Responsive

Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

for
Bipolar Depression
Location: 35 recruiting locations
Sponsor: Intra-Cellular Therapies, Inc.

Sex: All

Age: 10 - 17

Code: NCT06372964

Phase3, Recruiting
Active & Responsive

A Study Evaluating the Effectiveness and Safety of Risdiplam Administered in Pediatric Patients With Spinal Muscular Atrophy Who Experienced a Plateau or Decline in Function After Gene Therapy

for
Muscular Atrophy, Spinal
Location: 10 recruiting locations
Sponsor: Hoffmann-La Roche

Sex: All

Age: 0 - 2

Code: NCT05861999

Recruiting
Active & Responsive

Participants with Mild to Moderate Hidradenitis Suppurativa Will Receive EVO101 a Topical Cream 0.1%

for
Hidradenitis Suppurativa (HS)
Location: 1 recruiting location
Sponsor: Virginia Clinical Research, Inc.

Sex: All

Age: 18+

Code: NCT06645821

Early_phase1, Recruiting
Active & Responsive

A Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular Lymphoma

for
Lymphoma, Follicular
Location: 17 recruiting locations
Sponsor: Celgene

Sex: All

Age: 18+

Code: NCT06425302

Phase2, Recruiting
Active & Responsive

Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer

for
Breast Neoplasms, Brain Neoplasms, Neoplasms by Site, Neoplasms,
Location: 11 recruiting locations
Sponsor: Stemline Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05386108

Phase1, Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Study to Evaluate Contraceptive Efficacy and Safety of a Progestin Only Patch in Women of Childbearing Potential

for
Female Contraception
Location: 41 recruiting locations
Sponsor: Mylan Pharmaceuticals Inc

Sex: Female

Age: 16+

Code: NCT06672016

Phase3, Recruiting
Active & Responsive

Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)

for
Breast Neoplasms, Breast Cancer
Location: 8 recruiting locations
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06797635

Phase2, Recruiting
Active & Responsive

Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer

for
Breast Cancer, Metastatic Breast Cancer
Location: 34 recruiting locations
Sponsor: Stemline Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05563220

Phase1, Phase2, Recruiting
Active & Responsive

Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination With Chemotherapy

for
Locally Advanced Breast Cancer, Triple Negative Breast Cancer,
Location: 18 recruiting locations
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT06449222

Phase2, Recruiting
Active & Responsive

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: 34 recruiting locations
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT06297226

Phase2, Recruiting